What happened
Diagnostic infrastructuring: Biomarkers, pharmaceutical marketing and governance in Taiwan
SourceElsevier BVpublicationBiotech
Diagnostic infrastructuring: Biomarkers, pharmaceutical marketing and governance in Taiwan
Publication signal: Diagnostic infrastructuring: Biomarkers, pharmaceutical marketing and governance in Taiwan
Factual summary
Why it matters
Recent source-backed research output for AISci Stage A browsing.
SourceElsevier BVLimitations
AISci rank score does not assess scientific quality or citation impact.
SourceElsevier BVLinked output
Diagnostic infrastructuring: Biomarkers, pharmaceutical marketing and governance in TaiwanpaperPeople
No reviewed person relationship is attached to this event.
Organizations
No reviewed organization relationship is attached to this event.
Topics
Problems
No reviewed problem relationship is attached to this event.
Relationship evidence
Diagnostic infrastructuring: Biomarkers, pharmaceutical marketing and governance in Taiwan
Diagnostic infrastructuring: Biomarkers, pharmaceutical marketing and governance in Taiwan
Diagnostics and Biomarkers
Controlled AISci Stage A topic for Diagnostics and Biomarkers.
Timeline
- publicationDiagnostic infrastructuring: Biomarkers, pharmaceutical marketing and governance in Taiwan